Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Anticancer Res ; 41(11): 5835-5838, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34732459

RESUMO

BACKGROUND: Tumor-to-tumor (TMT) metastasis is a rare phenomenon in which a primary malignancy undergoes metastasis to an additional synchronous or metachronous primary tumor. CASE REPORT: This is a case report of a tumor-to-tumor metastasis from a poorly differentiated adenocarcinoma of the esophagus to a solitary fibrous tumor (SFT) of the right posterior neck, in a 70-year-old-male with a solitary right vertebral artery. After appropriate work-up and involvement of the necessary specialties, the patient underwent a complex surgical resection with negative margins. CONCLUSION: We present the unique case of a patient with TMT from esophageal adenocarcinoma to an SFT in the posterior neck, not previously reported in the literature. This rare condition with unique oncologic implications highlights the need for a multidisciplinary approach, in this case involving thoracic surgery, head-and-neck surgery, medical oncology, radiation oncology, pathology, and neurosurgical sub-specialty services.


Assuntos
Adenocarcinoma/secundário , Neoplasias Esofágicas/patologia , Neoplasias Primárias Múltiplas , Tumores Fibrosos Solitários/patologia , Adenocarcinoma/cirurgia , Idoso , Quimiorradioterapia Adjuvante , Neoplasias Esofágicas/cirurgia , Esofagectomia , Neoplasias de Cabeça e Pescoço/patologia , Neoplasias de Cabeça e Pescoço/cirurgia , Humanos , Masculino , Margens de Excisão , Esvaziamento Cervical , Terapia Neoadjuvante , Estadiamento de Neoplasias , Tumores Fibrosos Solitários/cirurgia , Resultado do Tratamento
2.
Arch Pathol Lab Med ; 145(2): 201-207, 2021 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-33501495

RESUMO

CONTEXT.­: Body fluid specimens are regularly submitted to the hematology laboratory for cell count and differential. Unless there is high clinical suspicion for malignancy, most cases lack concurrent cytology review and may not benefit from more focused examination for malignancy. OBJECTIVE.­: To compare rates of malignancy detection before and after fluid-focused training for hematology technologists as part of a quality improvement initiative. DESIGN.­: During an 8-week pretraining period, body fluids submitted to the cytology laboratory were correlated with concurrent hematology specimens. After slide review and training sessions for the hematology technologists, the same data were collected for a 4-week period. Discrepant cases were reviewed by hematology laboratory supervisors and pathologists. RESULTS.­: We collected 465 pretraining and 249 posttraining body fluids with concurrent cytology and hematology evaluation. In the pretraining cohort, 48 cases (10.3%) were diagnosed as malignant by cytology; of those, 33 were detected by hematology. In the posttraining cohort, 30 cases (12.0%) were diagnosed as malignant by cytology of which 27 were detected by hematology. Of the 18 discrepant cases (all carcinomas), hematology slide review showed definite features of malignancy in 15 and no tumor cells in 3. The malignancy detection rate by the hematology laboratory significantly improved after training (68.8% versus 90.0%, P = .01). CONCLUSIONS.­: We demonstrate the comparatively lower malignancy detection rate for body fluid specimens processed in our hematology laboratory, particularly for carcinomas. Hematology technologist education/training improved the malignancy detection rate, an important quality improvement given the large proportion of body fluids undergoing hematology evaluation without concurrent cytology reviews.


Assuntos
Líquidos Corporais/citologia , Carcinoma/diagnóstico , Laboratórios/normas , Citodiagnóstico , Eritroblastos/citologia , Testes Hematológicos , Hematologia , Humanos , Melhoria de Qualidade , Manejo de Espécimes
3.
J Mol Diagn ; 22(2): 208-219, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31751678

RESUMO

Myeloid neoplasms are a heterogeneous group of neoplasms including acute myeloid leukemia (AML), myeloproliferative neoplasms, myelodysplastic syndrome, and myeloproliferative neoplasms/myelodysplastic syndrome. Genetic abnormalities are used as diagnostic, prognostic, and predictive biomarkers in patients with these diseases. Herein, we describe the clinical validation of the Oncomine Myeloid Research (OMR) next-generation sequencing panel that interrogates for 40 genes and 29 fusion genes commonly seen in myeloid neoplasms. Our validation set of 77 DNA samples included acute and chronic myeloid neoplasms, with 91 single-nucleotide variants and small insertions/deletions. The 71 RNA samples from patients with AML included most of the AML-defining translocations. The OMR on the Ion Torrent S5 platform shows good performance in terms of depth of coverage, on-target reads, and uniformity. The panel achieved 91.3% and 100% concordance with reference DNA and RNA samples, respectively, with a clinical sensitivity and specificity of 96.7% and 100% for DNA and 99.8% and 100% for RNA, respectively. Precision and reproducibility were 100%, and the lower limit of detection was generally 5% variant allele fraction for DNA and 2-log reduction from initial value for RNA fusion genes. In conclusion, the OMR panel is a highly accurate and reproducible next-generation sequencing panel for the detection of common genetic alterations in myeloid neoplasms.


Assuntos
Predisposição Genética para Doença , Sequenciamento de Nucleotídeos em Larga Escala , Mutação INDEL , Células Mieloides/metabolismo , Proteínas de Fusão Oncogênica/genética , Polimorfismo de Nucleotídeo Único , Alelos , Biomarcadores Tumorais , Estudos de Associação Genética , Genótipo , Sequenciamento de Nucleotídeos em Larga Escala/métodos , Humanos , Células Mieloides/patologia , Transtornos Mieloproliferativos/diagnóstico , Transtornos Mieloproliferativos/genética , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
4.
Am J Clin Exp Urol ; 4(1): 12-6, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27069958

RESUMO

BACKGROUND: The human papilloma virus (HPV) is a carcinogen known for its strong association with cervical cancers and cervical lesions. It is also known to be associated with a variety of squamous cell carcinomas in other areas, such as the penis, vulva, anus and head and neck. However, the association with urothelial carcinoma remains controversial. Here, we report a case of urothelial carcinoma with squamous differentiation associated with HPV-6/HPV-11. CASE PRESENTATION: This is a case of a 70 year old man who presented with nocturia and pressure during urination. During the TURP procedure for what was clinically thought to be benign prostate hyperplasia with pathologic diagnosis as prostate carcinoma, a 2 cm papillary mass was found in the distal penile urethra. The papillary mass was found to be a high grade urothelial carcinoma positive for GATA 3 expression, with focal areas of squamous differentiation. The areas with squamous differentiation demonstrated koilocytic differentiation, which were positive for strong p16 expression. The tumor was found to harbor low risk HPV 6/11 by in situ hybridization. CONCLUSIONS: This study case demonstrates HPV infection with a low risk subtype (HPV 6/11) associated with an urothelial carcinoma with squamous differentiation and condylomatous features.

5.
Fed Pract ; 33(Suppl 5): 30S-34S, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-30766221

RESUMO

For patients with acute fulminant liver failure, imaging and histopathologic studies are indicated to reveal the underlying etiology, and metastatic small cell carcinoma should be included in the clinical differential diagnosis when appropriate.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...